UK Markets closed

Allscripts Healthcare Solutions, Inc. (MDRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.52-0.23 (-1.27%)
As of 02:54PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.00
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 323.25
52-week low 313.59
50-day moving average 318.24
200-day moving average 317.09

Share statistics

Avg vol (3-month) 31.34M
Avg vol (10-day) 31.02M
Shares outstanding 5122.57M
Implied shares outstanding 6N/A
Float 8108.22M
% held by insiders 12.42%
% held by institutions 1108.65%
Shares short (13 Oct 2022) 49.13M
Short ratio (13 Oct 2022) 46.32
Short % of float (13 Oct 2022) 412.84%
Short % of shares outstanding (13 Oct 2022) 48.24%
Shares short (prior month 14 Sept 2022) 410.14M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 316 Oct 2008
Ex-dividend date 406 Oct 2008
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 4.09%
Operating margin (ttm)4.33%

Management effectiveness

Return on assets (ttm)1.93%
Return on equity (ttm)9.67%

Income statement

Revenue (ttm)1.52B
Revenue per share (ttm)12.85
Quarterly revenue growth (yoy)6.90%
Gross profit (ttm)738.26M
EBITDA 111.33M
Net income avi to common (ttm)125.27M
Diluted EPS (ttm)4.75
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)500.16M
Total cash per share (mrq)4.51
Total debt (mrq)219.86M
Total debt/equity (mrq)18.38
Current ratio (mrq)3.23
Book value per share (mrq)11.94

Cash flow statement

Operating cash flow (ttm)188.56M
Levered free cash flow (ttm)133.47M